Newbury Pharmaceuticals AB (publ)
NEWBRY
Rank in Stocks
#30398
Newbury Pharmaceuticals AB (publ), a hybrid pharmaceutical enterprise, serves... Newbury Pharmaceuticals AB (publ), a hybrid pharmaceutical enterprise, serves both the Swedish and wider Scandinavian markets. Formed in 2020 and headquartered in Lund, Sweden, the company provides a variety of therapeutic solutions, with a strong emphasis on oncology, rare diseases, and neurology, in addition to other treatment categories.
Share Price
$0.17344444
Last synced: 2026-11-09
Market Cap
$5.27M
Change (1 day)
6.56%
Change (1 year)
-17.97%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Newbury Pharmaceuticals AB (publ) (NEWBRY)
Category
Healthcare
Operating Margin for Newbury Pharmaceuticals AB (publ) (NEWBRY)
Operating Margin as of November 2026 TTM: -48.40%
According to Newbury Pharmaceuticals AB (publ)'s latest financial reports, its current operating margin (TTM) is -48.40%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Newbury Pharmaceuticals AB (publ) from 2021 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -48.40% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -38.23% | -79.96% |
| 2023 | -190.79% | -28.25% |
| 2022 | -265.90% | 33.83% |
| 2021 | -198.69% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -101.29% |
US
|
|
| 31.60% | -100.65% |
SE
|
|
| 30.13% | -100.62% |
FR
|
|
| 29.76% | -100.61% |
HK
|
|
| 30.46% | -100.63% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Newbury Pharmaceuticals AB (publ)'s operating margin
What is Newbury Pharmaceuticals AB (publ)'s operating margin?
Newbury Pharmaceuticals AB (publ)'s operating margin is -48.40%, as of Nov 2026.
What was Newbury Pharmaceuticals AB (publ)'s operating margin in 2025?
In 2025, Newbury Pharmaceuticals AB (publ)'s operating margin was 0.00%, compared with -38.23% in 2024.
How has Newbury Pharmaceuticals AB (publ)'s operating margin changed since 2021?
From 2021 to 2025, Newbury Pharmaceuticals AB (publ)'s operating margin was highest in 2025 (0.00%) and lowest in 2022 (-265.90%).
How does Newbury Pharmaceuticals AB (publ)'s operating margin compare with similar companies?
Newbury Pharmaceuticals AB (publ)'s operating margin (-48.40%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.